New Chemical Tools for the Synthesis of Trisubstituted Hydroxylamines and their Application as Bioisosteres in Medicinal Chemistry

NIH RePORTER · NIH · R21 · $223,195 · view on reporter.nih.gov ↗

Abstract

This is a proposal to develop new tools for the practical effective synthesis of N,N,O- trisubstituted hydroxylamines, or hydroxalogs, as novel isosteres for application in medicinal chemistry across a broad swath of compound classes and diseases states. The three specific aims presented encompass i) tools development for the synthesis of N,N,O-trisubstituted hydroxylamines by a variety of inter- and intramolecular methods; ii) synthesis of a series of phenylpropylpiperidine ligands for the σ-1 and σ-2 receptors and their use as models for the comparative study of the physical and drug-like properties of the hydroxalogs, thereby enhancing their applicability as tools in medicinal chemistry; iii) synthesis of a series of hydroxalogs of the ethanolamine H1 antagonists and comparative determination of their antihistamine activity in a cell-based assay, again with the view to validating the hydroxalogs as isosteres as tools in medicinal chemistry.

Key facts

NIH application ID
10349762
Project number
1R21GM144753-01
Recipient
UNIVERSITY OF GEORGIA
Principal Investigator
David Crich
Activity code
R21
Funding institute
NIH
Fiscal year
2021
Award amount
$223,195
Award type
1
Project period
2021-09-15 → 2023-08-31